switzerlandde
Factor investing works

Factor investing works

06-01-2015 | Research

Factor investing is in vogue. Investors are increasingly focusing on factors such as value, low volatility, momentum and small cap. But what do we know about the relevance of factor investing?

  • Joop  Huij
    Joop
    Huij
    Head of Indices

Many studies have looked at the concept of factor investing. But how does it work in practice? Robeco quantitative researcher, Joop Huij, examined the data of approximately 7000 funds over the 1990-2010 period. His goal was to find out whether active managers with exposure to factor-based investment strategies consistently outperform their benchmarks. He used a regression-based method to show fund exposure to factors. “The results indicate that factor investing works in practice.”

Erhalten Sie regelmäßig aktuelle Informationen zu Factor Investing.
Erhalten Sie regelmäßig aktuelle Informationen zu Factor Investing.
Anmelden

How important is factor investing for active management?

My observation is that while factor investing can be highly effective, this does not necessarily hold true for all factors. You can turn the odds of success to your advantage by investing in proven factors. We therefore need to find out which factors do and which do not work. Some factors have been studied very thoroughly. Take, for example, value and low volatility. For these factors there seems to be consensus on the existence of statistical patterns and their significance after taking trading costs into account. For some factors there is also a vast amount of research into the reasons behind their existence. However, other factors such as short-term reversal and long-term reversal are still relatively unknown and there is as yet no academic consensus on their significance. These less-known factors also formed part of this study.

While we see many mutual funds in our database exposed to the small cap and value factors, other factors are  less popular. For instance, only 6% of all active-management strategies in our database are identified as low-volatility strategies. Within this 6%, only a small minority consciously engages in this strategy, for example by including screening on volatility. Only 1 to 2% of the mutual funds consistently follow a momentum strategy.

Are all factors doing well?

No. Short-term reversal is showing very poor performance. A short-term reversal strategy is designed to benefit from stocks that have performed badly in the recent past, but will outperform in the near future, or the reverse. A theoretical explanation for this is overreaction to stock-specific news by investors. However, 96% of all short- term reversal funds underperform the market. This outcome is not a complete surprise, since this strategy requires frequent portfolio rebalancing, which leads to high trading costs that ‘eat’ into net performance.

The research shows that what works best is a more conservative approach to factor investing that considers only those factors for which there is a large amount of evidence, as anomalies don’t just disappear. This contrasts to what I sometimes hear in the market, where brokers may say: ‘’Better to invest now in the latest factor before it is arbitraged away. No point in waiting until all the evidence is there; and don’t be too critical.” But my research shows that some factors, such as short-term reversal, simply don’t work.

‘The results indicate that factor investing works in practice’

What are your findings on momentum?

If you look at momentum, you will see that 38% of active managers that include a momentum factor achieve outperformance. This is less than in the value or low volatility universe, but still substantially more than the group not exposed to any factors. However, we also show that some managers exposed to momentum generate substantial underperformance. This is not totally unexpected. The literature warns that momentum investing can be a high-risk strategy. You need to implement it well to be successful. It is important to avoid two major pitfalls: first, excessive turnover levels that result in high trading costs; and second, exposures to unrewarded risks that do not contribute to achieving extra performance. 

What is the relevance of diversification to factor investing?

It is better not to invest in just one factor, but ideally to engage in diversification, because a single factor can result in underperformance in relation to the broad market for quite a considerable period of time.

Our study shows that a fund that does not engage in factor investing historically demonstrates  underperformance by on average 189 basis points per annum. I would call this result alarming. In contrast, a fund that is exposed to one random factor earns 163 extra basis points. With two random factors, this increases to 334 basis points, and with three factors, the result is even better: an outperformance of 353 basis points per annum. If you do not follow a factor-investing strategy as an active manager, your chances of outperforming are 20%. If you invest in one factor, they increase to 51%. This relates to a random factor and a random manager. If you choose three random factors and select a random manager, your chances will increase to 80%. If you choose the right factor and the right manager, your chances of outperformance could be even higher.

Logo

Zugangsbeschränkung / Haftungsausschluss

Die auf diesen Seiten enthaltenen Informationen dienen Marketingzwecken und sind ausschliesslich für (i) qualifizierte Anleger gemäss dem Schweizer Bundesgesetz über die kollektiven Kapitalanlagen vom 23. Juni 2006 („KAG“), (ii) Professionelle Kunden gemäss Anhang II der Richtlinie über Märkte für Finanzinstrumente (2014/65/EU; „MiFID II“) mit Sitz in der Europäischen Union oder im Europäischen Wirtschaftsraum mit einer entsprechenden Lizenz zur Erbringung von Vertriebs- / Angebotshandlungen im Zusammenhang mit Finanzinstrumenten oder für (iii) solche, die hiermit aus eigener Initiative entsprechende Informationen zu spezifischen Finanzinstrumenten erfragen und als professionelle Kunden qualifizieren.

Die Fonds haben ihren Sitz in Luxemburg oder den Niederlanden. Die ACOLIN Fund Services AG, Postanschrift: Affolternstrasse 56, 8050 Zürich, agiert als Schweizer Vertreter der Fonds. UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zürich, Postanschrift: Europastrasse 2, P.O. Box, CH-8152 Opfikon, fungiert als Schweizer Zahlstelle. Der Prospekt, die Key Investor Information Documents (KIIDs), die Satzung, die Jahres- und Halbjahresberichte der Fonds sind auf einfache Anfrage hin und kostenlos im beim Schweizer Vertreter ACOLIN Fund Services AG erhältlich. Die Prospekte sind auch über die Website www.robeco.ch verfügbar.

Einige Fonds, über die Informationen auf dieser Website angezeigt werden, fallen möglicherweise nicht in den Geltungsbereich des KAG und müssen daher nicht über eine entsprechende Genehmigung durch die Eidgenössische Finanzmarktaufsicht FINMA verfügen. Einige Fonds sind in Ihrem Wohnsitz- / Sitzstaat möglicherweise nicht verfügbar. Bitte überprüfen Sie den Registrierungsstatus in Ihrem jeweiligen Wohnsitz- / Sitzstaat. Um die in Ihrem Land registrierten Produkte anzuzeigen, gehen Sie bitte zur jeweiligen Länderauswahl, die auf dieser Website zu finden ist, und wählen Sie Ihr Wohnsitz- / Sitzstaat aus.

Weder Informationen noch Meinungen auf dieser Website stellen eine Aufforderung, ein Angebot oder eine Empfehlung zum Kauf, Verkauf oder einer anderweitigen Verfügung eines Finanzinstrumentes dar. Die Informationen auf dieser Webseite stellen keine Anlageberatung oder anderweitige Dienstleistung der Robeco Switzerland Ltd dar. Eine Investition in ein Produkt von Robeco Switzerland Ltd sollte erst erfolgen, nachdem die entsprechenden rechtlichen Dokumente wie Verwaltungsvorschriften, Prospekt, Jahres- und Halbjahresberichte konsultiert wurden.

Durch Klicken auf "Ich stimme zu" bestätigen Sie, dass Sie resp. die von Ihnen vertretene juristische Person eine der oben genannten Kategorien von Adressaten fallen und dass Sie die Nutzungsbedingungen für diese Website gelesen, verstanden und akzeptiert haben.

Nicht Zustimmen